Literature DB >> 15757366

Porphyrin-fullerene C60 dyads with high ability to form photoinduced charge-separated state as novel sensitizers for photodynamic therapy.

M Elisa Milanesio1, M Gabriela Alvarez, Viviana Rivarola, Juana J Silber, Edgardo N Durantini.   

Abstract

The photodynamic activities of a porphyrin-C60 dyad (P-C60) and its metal complex with Zn(II) (ZnP-C60) were compared with 5-(4-acetamidophenyl)-10,15,20-tris(4-methoxyphenyl)porphyrin (P), both in homogeneous medium-bearing photooxidizable substrates and in vitro on the Hep-2-human-larynx-carcinoma cell line. This study represents the first evaluation of dyads, with a high capacity to form a photoinduced charge-separated state, to act as agents to inactivate cells by photodynamic therapy (PDT). Absorption and fluorescence spectroscopic studies were performed in toluene and N,N-dimethylformamide (DMF). The emission of the porphyrin moiety in the dyads is strongly quenched by the attached fullerene C60 moiety. The singlet molecular oxygen, O2(1delta(g)), productions (phi(delta)) were determined using 9,10-dimethylanthracene (DMA). The values of phi(delta) were strongly dependent on the solvent's polarity. Comparable phi(delta) values were found for dyads and P in toluene, while O2(1delta(g)) production was significantly diminished for the dyads in DMF. In more polar solvent, the stabilization of charge-transfer state takes place, decreasing the efficiency of porphyrin triplet-state formation. Also, both dyads photosensitize the decomposition of L-tryptophan in DMF. In biological medium, no dark cytotoxicity was observed using sensitizer concentrations < or = 1 microM and 24 h of incubation. The uptake of sensitizers into Hep-2 was studied using 1 microM of sensitizer and different times of incubation. Under these conditions, a value of approximately 1.5 nmol/10(6) cells was found between 4 and 24 h of incubation. The cell survival after irradiation of the cells with visible light was dependent upon light-exposure level. A higher photocytotoxic effect was observed for P-C60, which inactivates 80% of cells after 15 min of irradiation. Moreover, both dyads keep a high photoactivity even under argon atmosphere. Thus, depending on the microenvironment where the sensitizer is localized, these compounds could produce biological photodamage through either an O2(1delta(g))-mediated photoreaction process or a free-radicals mechanism under low oxygen concentration. These results show that molecular dyads, which can form a photoinduced charge-separated state, are a promising model for phototherapeutic agents, with potential applications in cell inactivation by PDT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757366     DOI: 10.1562/2005-01-24-RA-426

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  11 in total

1.  Structure-Photoproperties Relationship Investigation of the Singlet Oxygen Formation in Porphyrin-Fullerene Dyads.

Authors:  Emel Önal; Sevinc Zehra Topal; Ismail Fidan; Savaş Berber; Fabienne Dumoulin; Catherine Hirel
Journal:  J Fluoresc       Date:  2017-06-30       Impact factor: 2.217

Review 2.  Functionalized fullerenes in photodynamic therapy.

Authors:  Ying-Ying Huang; Sulbha K Sharma; Rui Yin; Tanupriya Agrawal; Long Y Chiang; Michael R Hamblin
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

3.  Tetracyclines: light-activated antibiotics?

Authors:  Michael R Hamblin; Heidi Abrahamse
Journal:  Future Med Chem       Date:  2019-09-23       Impact factor: 3.808

Review 4.  Photodynamic therapy with fullerenes.

Authors:  Pawel Mroz; George P Tegos; Hariprasad Gali; Tim Wharton; Tadeusz Sarna; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2007-10-08       Impact factor: 3.982

5.  Fullerenes as photosensitizers in photodynamic therapy: pros and cons.

Authors:  Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2018-07-25       Impact factor: 3.982

6.  Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma.

Authors:  Pawel Mroz; Yumin Xia; Daisuke Asanuma; Aaron Konopko; Timur Zhiyentayev; Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Usman J Khan; Tim Wharton; Michael R Hamblin
Journal:  Nanomedicine       Date:  2011-05-19       Impact factor: 5.307

7.  Novel meso-substituted porphyrin derivatives and its potential use in photodynamic therapy of cancer.

Authors:  Pablo Vallecorsa; Gabriela Di Venosa; M Belén Ballatore; Dario Ferreyra; Leandro Mamone; Daniel Sáenz; Gustavo Calvo; Edgardo Durantini; Adriana Casas
Journal:  BMC Cancer       Date:  2021-05-13       Impact factor: 4.430

Review 8.  The application of titanium dioxide, zinc oxide, fullerene, and graphene nanoparticles in photodynamic therapy.

Authors:  Zahraa Youssef; Régis Vanderesse; Ludovic Colombeau; Francis Baros; Thibault Roques-Carmes; Céline Frochot; Habibah Wahab; Joumana Toufaily; Tayssir Hamieh; Samir Acherar; Amirah Mohd Gazzali
Journal:  Cancer Nanotechnol       Date:  2017-10-19

9.  Antimicrobial Photodynamic Inactivation Mediated by Tetracyclines in Vitro and in Vivo: Photochemical Mechanisms and Potentiation by Potassium Iodide.

Authors:  Weijun Xuan; Ya He; Liyi Huang; Ying-Ying Huang; Brijesh Bhayana; Liyan Xi; Jeffrey A Gelfand; Michael R Hamblin
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

Review 10.  Supramolecular Control of Singlet Oxygen Generation.

Authors:  Akshay Kashyap; Elamparuthi Ramasamy; Vijayakumar Ramalingam; Mahesh Pattabiraman
Journal:  Molecules       Date:  2021-05-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.